Respiratory Disposables Market by Product (Laryngoscope, Tubes, Breathing Bag, Masks, Resuscitator, and Others), Patient Group (Neonatal & Pediatric, Adult, and Geriatric), and End User (Hospitals, Nursing Homes, & Clinics; Trauma Centers; and Homecare): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4621812
- 172 Pages
- July 2021
- Medical Devices
Respiratory disposables are consumables that are used to interface respiratory devices with patients, such as nebulizers; ventilators; oxygen therapy devices; and disposable masks, resuscitators, & tubes. These disposables can be cast-off after their use in commenced period.
The risk of cross-contamination of infectious diseases, especially communicable lung disease, acts as a key driving force of the global respiratory disposables market. In addition, increase in prevalence of respiratory diseases worldwide coupled with steep rise in smoking by individuals are anticipated to help the market gain significant share in the coming years. Moreover, rise in exposure to toxic materials such as pollutants and harmful particulate matters is expected to propel the growth of the industry in the next few years. Furthermore, adverse climate conditions and air pollution are the major causes that increase the prevalence rate of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and obstructive sleep apnea (OSA), which, in turn, boost the demand for respiratory disposables, thereby augmenting the market growth. According to the statistics given by the American Society of Clinical Oncology Journal in 2020, incidence of patients with cancer is higher among females which is about 712,758 than in males, which is about 679,421 for the year 2020. The projected national cancer incidence burden in 2020 will be 98.7 per 100,000 population that is approximately 1,392,179 patients as a conservative estimate.
The global respiratory disposables market is segmented into product, patient group, end user and region. On the basis of product, the market is categorized into laryngoscope, tubes, breathing bag, masks, resuscitator, and others. The patient group segment is divided into neonatal & pediatric, adult, and geriatric. Depending on end user, the market is segregated into hospitals, nursing homes, & clinics; trauma centers; and homecare. The hospitals, nursing homes, & clinics is subdivided into neonatal & pediatric, adult, and geriatric. The trauma center is further segregated into neonatal & pediatric, adult, and geriatric. The homecare segment is subcategorized into neonatal & pediatric, adult, and geriatric. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It covers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of factors that drive and restrain the growth of the market is provided.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
• Laryngoscope
• Tubes
• Breathing Bag
• Masks
• Resuscitator
• Others
By Patient Group
• Neonatal & Pediatric
• Adult
• Geriatric
By End Users
• Hospitals, Nursing Homes, & Clinics
o Neonatal & Pediatric
o Adult
o Geriatric
• Trauma Centers
o Neonatal & Pediatric
o Adult
o Geriatric
• Homecare
o Neonatal & Pediatric
o Adult
o Geriatric
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Medtronic Plc.
• Masimo Corporation
• Fisher & Paykel Healthcare Corporation Limited
• Chart Industries Inc.
• Air Liquide S.A.
• Invacare Corporation
• Drägerwerk AG & Co. KGaA
• Getinge AB
• Hamilton Medical AG
• Smiths Group Plc. (Smith Medical Inc.)
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Surge in incidences of respiratory diseases affecting the respiratory system
3.5.1.2. Rise in product launches of respiratory disposables
3.5.1.3. Increase in the individuals who use cigarettes
3.5.1.4. Rise in the government initiatives for controlling rising pollution levels
3.5.2. Restraints
3.5.2.1. Higher rates of failures of disposables
3.5.3. Opportunity
3.5.3.1. Advent of novel viruses attacking respiratory system.
3.5.4. Impact analysis
3.6. COVID-19 Impact Analysis on respiratory disposables Market
CHAPTER 4: RESPIRATORY DISPOSABLES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Laryngoscope
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Tubes
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Breathing Bag
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Masks
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Resuscitator
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
CHAPTER 5: RESPIRATORY DISPOSABLES MARKET, BY PATIENT GROUP
5.1. Overview
5.1.1. Market size and forecast
5.2. Neonatal and Pediatric
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Adult
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.4. Geriatric
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
CHAPTER 6: RESPIRATORY DISPOSABLES MARKET, BY END USERS
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals, Nursing Homes & Clinics
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Market size and forecast, by type
6.2.5. Neonatal and Pediatric
6.2.5.1. Market size and forecast
6.2.6. Adult
6.2.6.1. Market size and forecast
6.2.7. Geriatric
6.2.7.1. Market size and forecast
6.3. Trauma Centers
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Market size and forecast, by type
6.3.5. Neonatal and Pediatric
6.3.5.1. Market size and forecast
6.3.6. Adult
6.3.6.1. Market size and forecast
6.3.7. Geriatric
6.3.7.1. Market size and forecast
6.4. Homecare
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
6.4.4. Market size and forecast, by type
6.4.5. Neonatal and Pediatric
6.4.5.1. Market size and forecast
6.4.6. Adult
6.4.6.1. Market size and forecast
6.4.7. Geriatric
6.4.7.1. Market size and forecast
CHAPTER 7: RESPIRATORY DISPOSABLES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size and forecast, by product
7.2.3. North America market size and forecast, by Patient group
7.2.4. North America market size and forecast, by end users
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Respiratory disposables market, for U.S., by product
7.2.5.1.2. Respiratory disposables market, for U.S., by Patient group
7.2.5.1.3. Respiratory disposables market, for U.S., by end users
7.2.5.2. Canada
7.2.5.2.1. Respiratory disposables market, for Canada, by product
7.2.5.2.2. Respiratory disposables market, for Canada, by Patient group
7.2.5.2.3. Respiratory disposables market, for Canada, by end users
7.2.5.3. Mexico
7.2.5.3.1. Respiratory disposables market, for Mexico, by product
7.2.5.3.2. Respiratory disposables market, for Mexico, by Patient group
7.2.5.3.3. Respiratory disposables market, for Mexico, by end users
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe market size and forecast, by product
7.3.3. Europe market size and forecast, by Patient group
7.3.4. Europe market size and forecast, by end users
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Respiratory disposables market, for Germany, by product
7.3.5.1.2. Respiratory disposables market, for Germany, by Patient group
7.3.5.1.3. Respiratory disposables market, for Germany, by end users
7.3.5.2. France
7.3.5.2.1. Respiratory disposables market, for France, by product
7.3.5.2.2. Respiratory disposables market, for France, by Patient group
7.3.5.2.3. Respiratory disposables market, for France, by end users
7.3.5.3. UK
7.3.5.3.1. Respiratory disposables market, for UK, by product
7.3.5.3.2. Respiratory disposables market, for UK, by Patient group
7.3.5.3.3. Respiratory disposables market, for UK, by end users
7.3.5.4. Italy
7.3.5.4.1. Respiratory disposables market, for Italy, by product
7.3.5.4.2. Respiratory disposables market, for Italy, by Patient group
7.3.5.4.3. Respiratory disposables market, for Italy, by end users
7.3.5.5. Spain
7.3.5.5.1. Respiratory disposables market, for Spain, by product
7.3.5.5.2. Respiratory disposables market, for Spain, by Patient group
7.3.5.5.3. Respiratory disposables market, for Spain, by end users
7.3.5.6. Rest of Europe
7.3.5.6.1. Respiratory disposables market, for Rest of Europe, by product
7.3.5.6.2. Respiratory disposables market, for Rest of Europe, by Patient group
7.3.5.6.3. Respiratory disposables market, for Rest of Europe, by end users
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by product
7.4.3. Asia-Pacific market size and forecast, by Patient group
7.4.4. Asia-Pacific market size and forecast, by end users
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Respiratory disposables market, for Japan, by product
7.4.5.1.2. Respiratory disposables market, for Japan, by Patient group
7.4.5.1.3. Respiratory disposables market, for Japan, by end users
7.4.5.2. China
7.4.5.2.1. Respiratory disposables market, for China, by product
7.4.5.2.2. Respiratory disposables market, for China, by Patient group
7.4.5.2.3. Respiratory disposables market, for China, by end users
7.4.5.3. India
7.4.5.3.1. Respiratory disposables market, for India, by product
7.4.5.3.2. Respiratory disposables market, for India, by Patient group
7.4.5.3.3. Respiratory disposables market, for India, by end users
7.4.5.4. South Korea
7.4.5.4.1. Respiratory disposables market, for South Korea, by product
7.4.5.4.2. Respiratory disposables market, for South Korea, by Patient group
7.4.5.4.3. Respiratory disposables market, for South Korea, by end users
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Respiratory disposables market, for Rest of Asia-Pacific, by product
7.4.5.5.2. Respiratory disposables market, for Rest of Asia-Pacific, by Patient group
7.4.5.5.3. Respiratory disposables market, for Rest of Asia-Pacific, by end users
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by product
7.5.3. LAMEA market size and forecast, by Patient group
7.5.4. LAMEA market size and forecast, by end users
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Respiratory disposables market, for Brazil, by product
7.5.5.1.2. Respiratory disposables market, for Brazil, by Patient group
7.5.5.1.3. Respiratory disposables market, for Brazil, by end users
7.5.5.2. South Africa
7.5.5.2.1. Respiratory disposables market, for South Africa, by product
7.5.5.2.2. Respiratory disposables market, for South Africa, by Patient group
7.5.5.2.3. Respiratory disposables market, for South Africa, by end users
7.5.5.3. Saudi Arabia
7.5.5.3.1. Respiratory disposables market, for Saudi Arabia, by product
7.5.5.3.2. Respiratory disposables market, for Saudi Arabia, by Patient group
7.5.5.3.3. Respiratory disposables market, for Saudi Arabia, by end users
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Respiratory disposables market, for Rest of LAMEA, by product
7.5.5.4.2. Respiratory disposables market, for Rest of LAMEA, by Patient group
7.5.5.4.3. Respiratory disposables market, for Rest of LAMEA, by end users
CHAPTER 8: COMPANY PROFILES
8.1. Medtronic plc
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Masimo Corporation
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Fisher & Paykel Healthcare Corporation Limited
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Chart Industries Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Air Liquide S.A.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Invacare Corporation
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Drägerwerk AG & Co. KGaA
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Getinge AB
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Hamilton Medical AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. Smiths Group plc (Smith Medical Inc.)
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
TABLE 01. RESPIRATORY DISPOSABLES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02. RESPIRATORY DISPOSABLES MARKET, FOR LARYNGOSCOPE, BY REGION, 2020–2030 ($MILLION)
TABLE 03. RESPIRATORY DISPOSABLES MARKET, FOR TUBES, BY REGION, 2020–2030 ($MILLION)
TABLE 04. RESPIRATORY DISPOSABLES MARKET, FOR BREATHING BAG, BY REGION, 2020–2030 ($MILLION)
TABLE 05. RESPIRATORY DISPOSABLES MARKET, FOR MASKS, BY REGION, 2020–2030 ($MILLION)
TABLE 06. RESPIRATORY DISPOSABLES MARKET, FOR RESUSCITATOR, BY REGION, 2020–2030 ($MILLION)
TABLE 07. RESPIRATORY DISPOSABLES MARKET, FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 08. RESPIRATORY DISPOSABLES MARKET, BY PATIENT GROUP, 2020–2030 ($MILLION)
TABLE 09. RESPIRATORY DISPOSABLES MARKET, FOR NEONATAL AND PEDIATRIC, BY REGION, 2020–2030 ($MILLION)
TABLE 10. RESPIRATORY DISPOSABLES MARKET, FOR ADULT, BY REGION, 2020–2030 ($MILLION)
TABLE 11. RESPIRATORY DISPOSABLES MARKET, FOR GERIATRIC, BY REGION, 2020–2030 ($MILLION)
TABLE 12. RESPIRATORY DISPOSABLES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 13. RESPIRATORY DISPOSABLES MARKET, FOR HOSPITALS, NURSING HOMES AND CLINICS, BY REGION, 2020–2030 ($MILLION)
TABLE 14. HOSPITALS, NURSING HOMES & CLINICS RESPIRATORY DISPOSABLES MARKET, BY TYPE, 2020-2030, ($MILLION)
TABLE 15. RESPIRATORY DISPOSABLES MARKET, FOR TRAUMA CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 16. TRAUMA CENTERS RESPIRATORY DISPOSABLES MARKET, BY TYPE, 2020-2030, ($MILLION)
TABLE 17. RESPIRATORY DISPOSABLES MARKET, FOR HOMECARE, BY REGION, 2020–2030 ($MILLION)
TABLE 18. HOMECARE RESPIRATORY DISPOSABLES MARKET, BY TYPE, 2020-2030, ($MILLION)
TABLE 19. RESPIRATORY DISPOSABLES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 20. RESPIRATORY DISPOSABLES MARKET, FOR NORTH AMERICA, BY PRODUCT, 2020–2030, ($MILLION)
TABLE 21. RESPIRATORY DISPOSABLES MARKET, FOR NORTH AMERICA, BY PATIENT GROUP, 2020–2030, ($MILLION)
TABLE 22. RESPIRATORY DISPOSABLES MARKET, FOR NORTH AMERICA, BY END USERS, 2020–2030, ($MILLION)
TABLE 23. RESPIRATORY DISPOSABLES MARKET, FOR NORTH AMERICA, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 24. RESPIRATORY DISPOSABLES MARKET, FOR U.S., BY PRODUCT, 2020–2030
TABLE 25. RESPIRATORY DISPOSABLES MARKET, FOR U.S., BY PATIENT GROUP, 2020–2030
TABLE 26. RESPIRATORY DISPOSABLES MARKET, FOR U.S., BY END USERS, 2020–2030
TABLE 27. RESPIRATORY DISPOSABLES MARKET, FOR CANADA, BY PRODUCT, 2020–2030
TABLE 28. RESPIRATORY DISPOSABLES MARKET, FOR CANADA, BY PATIENT GROUP, 2020–2030
TABLE 29. RESPIRATORY DISPOSABLES MARKET, FOR CANADA, BY END USERS, 2020–2030
TABLE 30. RESPIRATORY DISPOSABLES MARKET, FOR MEXICO, BY PRODUCT, 2020–2030
TABLE 31. RESPIRATORY DISPOSABLES MARKET, FOR MEXICO, BY PATIENT GROUP, 2020–2030
TABLE 32. RESPIRATORY DISPOSABLES MARKET, FOR MEXICO, BY END USERS, 2020–2030
TABLE 33. RESPIRATORY DISPOSABLES MARKET, FOR EUROPE, BY PRODUCT, 2020–2030, ($MILLION)
TABLE 34. RESPIRATORY DISPOSABLES MARKET, FOR EUROPE, BY PATIENT GROUP, 2020–2030, ($MILLION)
TABLE 35. RESPIRATORY DISPOSABLES MARKET, FOR EUROPE, BY END USERS, 2020–2030, ($MILLION)
TABLE 36. RESPIRATORY DISPOSABLES MARKET, FOR EUROPE RESPIRATORY DISPOSABLES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 37. RESPIRATORY DISPOSABLES MARKET, FOR GERMANY, BY PRODUCT, 2020–2030
TABLE 38. RESPIRATORY DISPOSABLES MARKET, FOR GERMANY, BY PATIENT GROUP, 2020–2030
TABLE 39. RESPIRATORY DISPOSABLES MARKET, FOR GERMANY, BY END USERS, 2020–2030
TABLE 40. RESPIRATORY DISPOSABLES MARKET, FOR FRANCE, BY PRODUCT, 2020–2030
TABLE 41. RESPIRATORY DISPOSABLES MARKET, FOR FRANCE, BY PATIENT GROUP, 2020–2030
TABLE 42. RESPIRATORY DISPOSABLES MARKET, FOR FRANCE, BY END USERS, 2020–2030
TABLE 43. RESPIRATORY DISPOSABLES MARKET, FOR UK, BY PRODUCT, 2020–2030
TABLE 44. RESPIRATORY DISPOSABLES MARKET, FOR UK, BY PATIENT GROUP, 2020–2030
TABLE 45. RESPIRATORY DISPOSABLES MARKET, FOR UK, BY END USERS, 2020–2030
TABLE 46. RESPIRATORY DISPOSABLES MARKET, FOR ITALY, BY PRODUCT, 2020–2030
TABLE 47. RESPIRATORY DISPOSABLES MARKET, FOR ITALY, BY PATIENT GROUP, 2020–2030
TABLE 48. RESPIRATORY DISPOSABLES MARKET, FOR ITALY, BY END USERS, 2020–2030
TABLE 49. RESPIRATORY DISPOSABLES MARKET, FOR SPAIN, BY PRODUCT, 2020–2030
TABLE 50. RESPIRATORY DISPOSABLES MARKET, FOR SPAIN, BY PATIENT GROUP, 2020–2030
TABLE 51. RESPIRATORY DISPOSABLES MARKET, FOR SPAIN, BY END USERS, 2020–2030
TABLE 52. RESPIRATORY DISPOSABLES MARKET, FOR REST OF EUROPE, BY PRODUCT, 2020–2030
TABLE 53. RESPIRATORY DISPOSABLES MARKET, FOR REST OF EUROPE, BY PATIENT GROUP, 2020–2030
TABLE 54. RESPIRATORY DISPOSABLES MARKET, FOR REST OF EUROPE, BY END USERS, 2020–2030
TABLE 55. RESPIRATORY DISPOSABLES MARKET, FOR ASIA-PACIFIC, BY PRODUCT, 2020–2030, ($MILLION)
TABLE 56. RESPIRATORY DISPOSABLES MARKET, FOR ASIA-PACIFIC, BY PATIENT GROUP, 2020–2030, ($MILLION)
TABLE 57. RESPIRATORY DISPOSABLES MARKET, FOR ASIA-PACIFIC, BY END USERS, 2020–2030, ($MILLION)
TABLE 58. RESPIRATORY DISPOSABLES MARKET, FOR ASIA-PACIFIC , BY COUNTRY, 2020–2030 ($MILLION)
TABLE 59. RESPIRATORY DISPOSABLES MARKET, FOR JAPAN, BY PRODUCT, 2020–2030
TABLE 60. RESPIRATORY DISPOSABLES MARKET, FOR JAPAN, BY PATIENT GROUP, 2020–2030
TABLE 61. RESPIRATORY DISPOSABLES MARKET, FOR JAPAN, BY END USERS, 2020–2030
TABLE 62. RESPIRATORY DISPOSABLES MARKET, FOR CHINA, BY PRODUCT, 2020–2030
TABLE 63. RESPIRATORY DISPOSABLES MARKET, FOR CHINA, BY PATIENT GROUP, 2020–2030
TABLE 64. RESPIRATORY DISPOSABLES MARKET, FOR CHINA, BY END USERS, 2020–2030
TABLE 65. RESPIRATORY DISPOSABLES MARKET, FOR INDIA, BY PRODUCT, 2020–2030
TABLE 66. RESPIRATORY DISPOSABLES MARKET, FOR INDIA, BY PATIENT GROUP, 2020–2030
TABLE 67. RESPIRATORY DISPOSABLES MARKET, FOR INDIA, BY END USERS, 2020–2030
TABLE 68. RESPIRATORY DISPOSABLES MARKET, FOR SOUTH KOREA, BY PRODUCT, 2020–2030
TABLE 69. RESPIRATORY DISPOSABLES MARKET, FOR SOUTH KOREA, BY PATIENT GROUP, 2020–2030
TABLE 70. RESPIRATORY DISPOSABLES MARKET, FOR SOUTH KOREA, BY END USERS, 2020–2030
TABLE 71. RESPIRATORY DISPOSABLES MARKET, FOR REST OF ASIA-PACIFIC, BY PRODUCT, 2020–2030
TABLE 72. RESPIRATORY DISPOSABLES MARKET, FOR REST OF ASIA-PACIFIC, BY PATIENT GROUP, 2020–2030
TABLE 73. RESPIRATORY DISPOSABLES MARKET, FOR REST OF ASIA-PACIFIC, BY END USERS, 2020–2030
TABLE 74. RESPIRATORY DISPOSABLES MARKET, FOR LAMEA, BY PRODUCT, 2020–2030, ($MILLION)
TABLE 75. RESPIRATORY DISPOSABLES MARKET, FOR LAMEA, BY PATIENT GROUP, 2020–2030, ($MILLION)
TABLE 76. RESPIRATORY DISPOSABLES MARKET, FOR LAMEA, BY END USERS, 2020–2030, ($MILLION)
TABLE 77. RESPIRATORY DISPOSABLES MARKET, FOR LAMEA, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 78. RESPIRATORY DISPOSABLES MARKET, FOR BRAZIL, BY PRODUCT, 2020–2030
TABLE 79. RESPIRATORY DISPOSABLES MARKET, FOR BRAZIL, BY PATIENT GROUP, 2020–2030
TABLE 80. RESPIRATORY DISPOSABLES MARKET, FOR BRAZIL, BY END USERS, 2020–2030
TABLE 81. RESPIRATORY DISPOSABLES MARKET, FOR SOUTH AFRICA, BY PRODUCT, 2020–2030
TABLE 82. RESPIRATORY DISPOSABLES MARKET, FOR SOUTH AFRICA, BY PATIENT GROUP, 2020–2030
TABLE 83. RESPIRATORY DISPOSABLES MARKET, FOR SOUTH AFRICA, BY END USERS, 2020–2030
TABLE 84. RESPIRATORY DISPOSABLES MARKET, FOR SAUDI ARABIA, BY PRODUCT, 2020–2030
TABLE 85. RESPIRATORY DISPOSABLES MARKET, FOR SAUDI ARABIA, BY PATIENT GROUP, 2020–2030
TABLE 86. RESPIRATORY DISPOSABLES MARKET, FOR SAUDI ARABIA, BY END USERS, 2020–2030
TABLE 87. RESPIRATORY DISPOSABLES MARKET, FOR REST OF LAMEA, BY PRODUCT, 2020–2030
TABLE 88. RESPIRATORY DISPOSABLES MARKET, FOR REST OF LAMEA, BY PATIENT GROUP, 2020–2030
TABLE 89. RESPIRATORY DISPOSABLES MARKET, FOR REST OF LAMEA, BY END USERS, 2020–2030
TABLE 90. MEDTRONIC: COMPANY SNAPSHOT
TABLE 91. MEDTRONIC: OPERATING SEGMENTS
TABLE 92. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 93. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. MASIMO: COMPANY SNAPSHOT
TABLE 95. MASIMO: OPERATING SEGMENTS
TABLE 96. MASIMO: PRODUCT PORTFOLIO
TABLE 97. FPH: COMPANY SNAPSHOT
TABLE 98. FPH: OPERATING SEGMENTS
TABLE 99. FPH: PRODUCT PORTFOLIO
TABLE 100. FPH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. CHART INDUSTRIES: COMPANY SNAPSHOT
TABLE 102. CHART INDUSTRIES: OPERATING SEGMENTS
TABLE 103. CHART INDUSTRIES: PRODUCT PORTFOLIO
TABLE 104. AIR LIQUIDE: COMPANY SNAPSHOT
TABLE 105. MEDTRONIC: OPERATING SEGMENTS
TABLE 106. AIR LIQUIDE: PRODUCT PORTFOLIO
TABLE 107. AIR LIQUIDE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. INVACARE: COMPANY SNAPSHOT
TABLE 109. INVACARE: OPERATING SEGMENTS
TABLE 110. INVACARE: PRODUCT PORTFOLIO
TABLE 111. DRÄGERWERK AG: COMPANY SNAPSHOT
TABLE 112. DRÄGERWERK AG: OPERATING SEGMENTS
TABLE 113. DRÄGERWERK AG: PRODUCT PORTFOLIO
TABLE 114. DRÄGERWERK AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. GETINGE: COMPANY SNAPSHOT
TABLE 116. GETINGE: OPERATING SEGMENTS
TABLE 117. GETINGE: PRODUCT PORTFOLIO
TABLE 118. HAMILTON MEDICAL: COMPANY SNAPSHOT
TABLE 119. HAMILTON MEDICAL: OPERATING SEGMENTS
TABLE 120. HAMILTON MEDICAL: PRODUCT PORTFOLIO
TABLE 121. HAMILTON MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. SMITHS GROUP: COMPANY SNAPSHOT
TABLE 123. SMITHS GROUP: OPERATING SEGMENTS
TABLE 124. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 125. SMITHS GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
